Pelican Cancer Foundation

Pelican Cancer Foundation

  • Facebook
  • Instagram
  • Twitter
  • YouTube
DONATE NOW
  • Home
  • About Us
    • What we do
      • Bowel cancer
      • Colorectal Liver Metastases
      • Prostate cancer
      • Bladder cancer
      • Pseudomyxoma peritonei
      • Our Research
      • Our achievements
      • Media
    • Who we are
      • Our board
      • Our team
      • Pelican Patrons
    • Our annual accounts
    • Pelican Cancer Foundation – What next?
    • Support Us
    • Job opportunities
    • Partners
  • Workshops
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • What clinicians say about our courses
    • Faculty
    • Our sponsors
    • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Videos
  • Research
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Prostate Cancer Research
      • Focal therapy and HIFU research
      • MRI research for prostate cancer
      • Prostate cancer colloquiums
      • FORECAST
      • Trachtomap
      • Papers of interest
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Bladder cancer research
      • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for researchers
      • Peer review process
      • Research review panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Jay’s story (bladder cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Prostate cancer
      • Our prostate cancer team
      • Prostate cancer treatment options
      • Pelican’s position
    • Bladder cancer
      • Blue light cystoscopy
      • Bladder cancer – useful contacts
    • Pseudomyxoma peritonei
    • Kidney cancer
      • Our kidney cancer team
      • Kidney cancer – useful contacts
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Why donate to Pelican?
      • Donate shares
      • Donate in memory
      • How your donations are spent
    • Fundraising
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
      • Our events
    • Leaving a Legacy
    • Volunteering Opportunities
    • Could you host a Pelican Talk?
    • Charity of the Year partnerships
    • Pelican Film Society
  • Shop
  • Events
  • Contact us

Bowel Cancer Research

October 16, 2017 by pelicanadmin

Bowel cancer research

D-researcher_labelling_tube

Pelican supports research that informs and improves bowel cancer treatment today. The charity’s research studies to date have underlined that a multi-disciplinary approach to treatment is vital to achieving the best possible outcome for bowel cancer patients.

The Total Mesorectal Excision (TME) precise surgical technique that was pioneered by Professor Bill Heald, founder of the Pelican Cancer Foundation. TME saves more lives than any other treatment for bowel cancer. It halves the chance of the cancer returning and reduces negative side effects such as damage to urinary and sexual function. TME has already made a life-saving, life-enhancing difference to thousands of patients all over the world.

Following this direction Pelican has continued to aid ground-breaking research into bowel cancer. Their first major research programme, MERCURYinvestigated the role of MRI in detecting and clearly staging disease, and in planning precision surgery. The study found that MRI could identify the features of a lower bowel (rectal) tumour pre-operatively, allowing for individualised optimal treatment, to be planned by the multi-disciplinary team, including pre-operative therapies, such as radio- or chemotherapy which can shrink the tumours.

MRI allows early tumours to be identified, for which surgery alone is best and pre-operative therapy is not necessary. By informing clinical decision-making, MRI is now providing an opportunity to downstage even poor prognosis rectal tumours and improve patient outcomes.

Building on the wealth of data from the MERCURY project, one of Pelican’s principle research projects at the moment, MERCURY II (Low Rectal Cancer Study), is investigating the ability of MRI-planned surgery and selective pre-operative therapy to reduce the rates of local tumour recurrence and improve overall survival for patients. This is the work of Nick Battersby, based at the Pelican Centre under the project leadership of Mr Brendan Moran and Professor Gina Brown.

Another significant area of research that Pelican is involved in is the Deferral of Surgery Study at the Royal Marsden Hospital. This research looks at the tumour response in low rectal cancers to pre-operative chemoradiation and whether, if it is good, surgery can be safely delayed or avoided to improve patient quality of life. It aims to establish the time needed for maximum down-staging of the tumour and therefore the optimum timing for surgery. In a small number of cases surgery can be avoided altogether but the challenge is discovering which tumours are most likely to respond.

Filed Under: Uncategorized

Pelican Cancer FoundationFollow

Driving innovation and advancing surgery to help patients live well, for longer.

Pelican Cancer Foundation
ChrisGBoultonChris Boulton@ChrisGBoulton·
12 May

Today's taster of my Big Mountains Exhibition at the @westridgestudio Highclere on 21/22 May is my triptych of the Monte Rosa Massif. #oswbnh2022 #westridgestudio #artexibition #openstudios #bigmountains #alpsmountains #monterosa #pelicancancerfoundation #mycancermychoices

Reply on Twitter 1524787378711404545Retweet on Twitter 15247873787114045451Like on Twitter 15247873787114045451Twitter 1524787378711404545
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
10 May

👇 Available to watch now - http://pelicancancervideos.org
🎥Lapco - training laparoscopic colorectal surgeons

@TomCecilMD @lapcoleadmark @Brendan92855812 @ProfessorHeald

Reply on Twitter 1523904919253786625Retweet on Twitter 15239049192537866256Like on Twitter 15239049192537866258Twitter 1523904919253786625
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
9 May

👇 Available to tomorrow 10/05/2022 - @TomCecilMD @lapcoleadmark @Brendan92855812
@ProfessorHeald discuss 'Lapaco - training laparoscopic colorectal surgeons'

Reply on Twitter 1523682093058129920Retweet on Twitter 15236820930581299202Like on Twitter 15236820930581299203Twitter 1523682093058129920
Load More...

To view our privacy policy - click here.
Registered charity no: 1141911

Copyright © 2022 · Outreach Pro Theme on Genesis Framework · WordPress · Log in